{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T00:42:07Z","timestamp":1759624927236,"version":"build-2065373602"},"reference-count":5,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurology and Neurosurgery"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.clineuro.2020.106048","type":"journal-article","created":{"date-parts":[[2020,6,25]],"date-time":"2020-06-25T11:37:46Z","timestamp":1593085066000},"page":"106048","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Unwarranted, long term, alglucosidase alfa enzyme replacement therapy in two non-Pompe disease patients"],"prefix":"10.1016","volume":"196","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3868-2994","authenticated-orcid":false,"given":"Chafic","family":"Karam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Ragole","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Orly","family":"Moshe-Lilie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nizar","family":"Chahin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"April (15)","key":"10.1016\/j.clineuro.2020.106048_bib0005","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1056\/NEJMoa0909859","article-title":"A randomized study of alglucosidase alfa in late-onset Pompe\u2019s disease","volume":"362","author":"van der Ploeg","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clineuro.2020.106048_bib0010","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ymgme.2009.12.014","article-title":"Genetic heterozygosity and pseudodeficiency in the Pompe disease newborn screening pilot program","volume":"99","author":"Labrousse","year":"2010","journal-title":"Mol. Genet. Metab."},{"issue":"April (4)","key":"10.1016\/j.clineuro.2020.106048_bib0015","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1373\/clinchem.2016.259036","article-title":"Liquid chromatography-tandem mass spectrometry assay of leukocyte acid \u03b1-glucosidase for post-newborn screening evaluation of pompe disease","volume":"63","author":"Lin","year":"2017","journal-title":"Clin. Chem."},{"issue":"4","key":"10.1016\/j.clineuro.2020.106048_bib0020","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ymgme.2017.10.008","article-title":"Sensitivity of whole exome sequencing in detecting infantile- and late-onset Pompe disease","volume":"122","author":"Mori","year":"2017","journal-title":"Mol. Genet. Metab."},{"issue":"10","key":"10.1016\/j.clineuro.2020.106048_bib0025","first-page":"1219","article-title":"The incidence of tonsillectomy in school children","volume":"31","author":"Glover","year":"1938","journal-title":"Proc. R. Soc. Med."}],"container-title":["Clinical Neurology and Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846720303917?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846720303917?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T14:36:33Z","timestamp":1759588593000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303846720303917"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":5,"alternative-id":["S0303846720303917"],"URL":"https:\/\/doi.org\/10.1016\/j.clineuro.2020.106048","relation":{},"ISSN":["0303-8467"],"issn-type":[{"type":"print","value":"0303-8467"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unwarranted, long term, alglucosidase alfa enzyme replacement therapy in two non-Pompe disease patients","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurology and Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clineuro.2020.106048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106048"}}